![Psychedelic medicine pioneer exits MDMA biotech after regulatory blow](https://cdn.newsserve.net/ONPglobe256.png)
Psychedelic medicine pioneer exits MDMA biotech after regulatory blow
Doblin leaves Lykos Therapeutics board after work on treatment for PTSD suffered setback from FDA ruling
Full Article
Doblin leaves Lykos Therapeutics board after work on treatment for PTSD suffered setback from FDA ruling
Full Article